Rajendran Dhanalakshmi

Rajendran Dhanalakshmi

Auto-generated profile, based on publicly available information

Rajendran Dhanalakshmi

Affiliation ICMR-Vector Control Research Centre, Puducherry, India

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NGNarendran Gopalan
Narendran Gopalan
SSSumathi Senthil
Sumathi Senthil
NPNarmadha Lakshmi Prabakar
Narmadha Lakshmi Prabakar
TSThirumaran Senguttuvan
Thirumaran Senguttuvan
ABAdhin Bhaskar
Adhin Bhaskar
PCPadmapriyadarsini Chandrasekaran
Padmapriyadarsini Chandrasekaran
Background: We retrospectively data-mined the case records of Reverse Transcription Polymerase Chain Reaction (RT-PCR) confirmed COVID-19 patients hospitalized to a tertiary care centre to derive mortality predictors and formulate a risk score, for prioritizing admission. Methods and findings: Data on clinical manifestations, comorbidities, vital signs, and basic lab investigations collected as part of routine medical management at admission to a COVID-19 tertiary care centre in Chengalpattu, South India between May and November 2020 were retrospectively analysed to ascertain predictors of mortality in the univariate analysis using their relative difference in distribution among ‘survivors’ and ‘non-survivors’. The regression coefficients of those factors remaining significant in the multivariable logistic regression were utilised for risk score formulation and validated in 1000 bootstrap datasets. Among 746 COVID-19 patients hospitalised [487 “survivors” and 259 “non-survivors” (deaths)], there was a slight male predilection [62.5%, (466/746)], with a higher mortality rate observed among 40–70 years age group [59.1%, (441/746)] and highest among diabetic patients with elevated urea levels [65.4% (68/104)]. The adjusted odds ratios of factors [OR (95% CI)] significant in the multivariable logistic regression were SaO23; 3.01 (1.61–5.83), Age ≥50 years;2.52 (1.45–4.43), Pulse Rate ≥100/min: 2.02 (1.19–3.47) and coexisting Diabetes Mellitus; 1.73 (1.02–2.95) with hypertension and gender not retaining their significance. The individual risk scores for SaO23–11, Age ≥50 years-9, Pulse Rate ≥100/min-7 and coexisting diabetes mellitus-6, acronymed collectively as ‘OUR-ARDs score’ showed that the sum of scores ≥ 25 predicted mortality with a sensitivity-90%, specificity-64% and AUC of 0.85. Conclusions: The ‘OUR ARDs’ risk score, derived from easily assessable factors predicting mortality, offered a tangible solution for prioritizing admission to COVID-19 tertiary care centre, that enhanced patient care but without unduly straining the health system.

1 August 2025 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
KKKaliannagounder Krishnamoorthy
Kaliannagounder Krishnamoorthy
RDRaja Jeyapal Dinesh
Raja Jeyapal Dinesh
RDRajendran Dhanalakshmi
Rajendran Dhanalakshmi
PJPriskilla Johnson Jency
Priskilla Johnson Jency
PAPalappurath Maliyakkal Azad
Palappurath Maliyakkal Azad
AKAshwani Kumar
Ashwani Kumar
Background: Mass Drug Administration (MDA) with triple-drug regimen (Ivermectin, Diethylcarbamazine, and Albendazole- IDA), recommended by the World Health Organization (WHO) was introduced in India in 2018, as an alternate strategy to two drug regimens (Diethylcarbamazine, and Albendazole- DA), for accelerating lymphatic filariasis (LF) elimination. By December 2023, IDA-MDA has been implemented in 63 LF endemic districts in India. The currently followed monitoring and evaluation (M&E) guidelines for DA may not be suitable to this new strategy. The WHO is developing a new M&E guideline for IDA-based MDA which recommends surveys referred to as Epidemiological Monitoring Survey (EMS) before the IDA Impact Survey (IIS), similar to pre-transmission assessment survey (preTAS) and transmission assessment survey (TAS) for DA-based MDA. The National Centre for Vector Borne Disease Control (NCVBDC) recently revised its M&E guidelines and downsized the evaluation unit to the health block from district level. In the present study, an EMS was conducted in two health blocks of Bidar district in Karnataka, India, in July 2023, following two effective rounds of IDA-MDA to assess its eligibility for an IIS. Methods: Two sentinel and one random site in each block were selected for the EMS, as per NCVBDC guidelines. A minimum sample of 300 individuals aged ≥20 years was tested for circulating filarial antigen (CFA) using filariasis test strips (FTS) in each site. Night blood smears were collected from CFA-positive individuals and examined for microfilaria (Mf). A Mf prevalence threshold of <1% in each site was used as a decision rule on whether to stop MDA and proceed with IIS or continue with MDA in the health block. The data were expressed as proportions with 95% confidence intervals, and a p-value <0·05 was considered statistically significant. Results: The number of individuals tested for CFA ranged from 303 to 314 in each of the six sites selected for EMS. The prevalence of CFA was above the threshold of 2% (3·6% to 31·1%) in all sites in both health blocks. Overall, 1846 individuals were screened, of which 343 (18·6%) were positive for CFA. Of the 320 individuals screened for microfilaremia, 71 were positive for Mf. All four sentinel sites in the two blocks had Mf prevalence above the threshold of 1%, ranging from 3·7 to 7·4%. The Mf count was 1–242 per 60µl of blood per positive person, and the geometric mean Mf density was 0·83 (±3·5) in the four sentinel sites. Both CFA (30·7%) and Mf (8·5%) prevalence was significantly higher in males. Nearly 42·0% of respondents self-reported not participating in both rounds of IDA-MDA, and it was significantly higher among males (52·4%). Also, the infection rates (CFA and Mf) were higher among those who did not participate in the two IDA-MDA rounds. Conclusions: Both the health blocks in Bidar district are not eligible for stopping MDA after two rounds of IDA-MDA, indicating the need for at least two additional rounds of MDA as per WHO guideline. The study suggests that the EMS strategy is operationally feasible which the other IDA-MDA districts can follow.

10 November 2023 in BMC Public Health
Verified
Journal Article
Open access
PDF file
RDRaja Jeyapal Dinesh
Raja Jeyapal Dinesh
RDRajendran Dhanalakshmi
Rajendran Dhanalakshmi
PJPriskilla Johnson Jency
Priskilla Johnson Jency
ASAdinarayanan Srividya
Adinarayanan Srividya
BVBalakrishnan Vijayakumar
Balakrishnan Vijayakumar
AKAshwani Kumar
Ashwani Kumar
Background: Vaccine hesitancy is a complex phenomenon that threatens global health. Present-day communication technology has paved the way for self-education but also contributed to the infodemic surrounding vaccination. This has resulted in pockets of people who are reluctant, refuse recommended vaccinations, or choose to delay being vaccinated. The present study was designed to estimate the magnitude of hesitancy towards the COVID-19 vaccination and determine its associated factors in the community. Methods: This cross-sectional study was conducted among 776 adults aged ≥ 18 years in 15 clusters in Puducherry district, India, between March 2022 and May 2022. Face-to-face interviews were conducted using a validated, structured questionnaire. Socio-demographic variables, co-morbidities, attitudes towards vaccination, etc., were expressed as frequencies and percentages. Vaccine hesitancy was dichotomized with the median score as the cut-off and reported as a proportion with a 95% confidence interval. Univariate and multivariate analyses were carried out to determine the factors associated with vaccine hesitancy. Results: The mean age of participants was 43.3 ± 14.8 years, with the majority being female (67.0%). Nearly 92.4%, 74.4%, and 0.5% of participants received their first, second, and precautionary doses, respectively, during the study period. Among the unvaccinated, 93.2% were unwilling to receive any dose of vaccination. More than half of the participants were hesitant towards vaccination, according to the vaccine hesitancy scale. Participants aged above 45 years were less hesitant, while those educated up to school level, belonging to the upper socio-economic class, never tested for COVID-19 in the past, and having a negative attitude towards vaccination were significantly associated with higher vaccine hesitancy. Conclusions: It is imperative to address vaccine hesitancy by alleviating existing fears and misconceptions in the community through efficient communication strategies to win the fight against current as well as future public health emergencies.